Detection of tetracosactide in plasma by enzyme-linked immunosorbent assay (ELISA)

Gespeichert in:
Bibliographische Detailangaben
Deutscher übersetzter Titel:Nachweis von Tetracosactid im Blutplasma durch "Enzyme Linked Immunosorbent Assay" (ELISA)
Autor:Martin, Laurent; Chaabo, Ayman; Lasne, Francoise
Erschienen in:Drug testing and analysis
Veröffentlicht:7 (2015), 5-6, S. 531-534, Lit.
Format: Literatur (SPOLIT)
Publikationstyp: Zeitschriftenartikel
Medienart: Elektronische Ressource (online) Gedruckte Ressource
Sprache:Englisch
ISSN:1942-7603, 1942-7611
DOI:10.1002/dta.1705
Schlagworte:
Online Zugang:
Erfassungsnummer:PU201509007411
Quelle:BISp

Abstract

As a synthetic analogue of adrenocorticotropic hormone (ACTH), tetracosactide is prohibited in sport by the World Anti-Doping Agency (WADA). An enzyme-linked immunosorbent assay (ELISA) method is proposed for detection of this drug in plasma. Since its structure corresponds to the 24 N-terminal of the 39 amino acids of the natural endogenous peptide ACTH, tetracosactide can be detected with a commercial ELISA kit for ACTH that uses antibodies, the epitopes of which are located in the 1‒24 part of ACTH. However, an essential condition for detection specificity is the preliminary total clearance of endogenous ACTH in the plasma samples. This is achieved by a preparative step based on cation-exchange chromatography before ELISA. The method is specific and sensitive (LOD: 30 pg/mL) and may be used as a screening analysis in anti-doping control. The pre-analytical conditions are shown to be of the upmost importance and recommendations for blood collection (EDTA tubes), sample transport (4 °C) and plasma sample storage (-20 °C) are presented. Verf.-Referat